192 related articles for article (PubMed ID: 24589354)
21. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
23. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
[TBL] [Abstract][Full Text] [Related]
24. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.
Bernstein JM; Brooks SP; Lehman HK; Pope L; Sands A; Shultz LD; Bankert RB
Ann Otol Rhinol Laryngol; 2009 Dec; 118(12):866-75. PubMed ID: 20112521
[TBL] [Abstract][Full Text] [Related]
25. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity.
Nishime C; Kawai K; Yamamoto T; Katano I; Monnai M; Goda N; Mizushima T; Suemizu H; Nakamura M; Murata M; Suematsu M; Wakui M
J Immunol; 2015 Aug; 195(4):1883-90. PubMed ID: 26170385
[TBL] [Abstract][Full Text] [Related]
26. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
27. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
[TBL] [Abstract][Full Text] [Related]
28. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy of human embryonic stem cell-derived endothelial cells in humanized mouse models harboring a human immune system.
Yang HM; Moon SH; Choi YS; Park SJ; Lee YS; Lee HJ; Kim SJ; Chung HM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2839-49. PubMed ID: 24092748
[TBL] [Abstract][Full Text] [Related]
30. Assessment of benzene-induced hematotoxicity using a human-like hematopoietic lineage in NOD/Shi-scid/IL-2Rγnull mice.
Takahashi M; Tsujimura N; Yoshino T; Hosokawa M; Otsuka K; Matsunaga T; Nakasono S
PLoS One; 2012; 7(12):e50448. PubMed ID: 23226520
[TBL] [Abstract][Full Text] [Related]
31. Differential radiation sensitivity to morphological, functional and molecular changes of human thyroid tissues and bone marrow cells maintained in SCID mice.
Nomura T; Hongyo T; Nakajima H; Li LY; Syaifudin M; Adachi S; Ryo H; Baskar R; Fukuda K; Oka Y; Sugiyama H; Matsuzuka F
Mutat Res; 2008 Nov; 657(1):68-76. PubMed ID: 18778792
[TBL] [Abstract][Full Text] [Related]
32. Model of the athymic nude mouse for the study of benign goiter disease.
Gerber H; Wagner HE; Bürgi U; Peter HJ
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 3():56-9. PubMed ID: 8986427
[TBL] [Abstract][Full Text] [Related]
33. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
Ito M; Kobayashi K; Nakahata T
Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
[TBL] [Abstract][Full Text] [Related]
34. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg
Nagatani M; Kodera T; Suzuki D; Igura S; Fukunaga Y; Kanemitsu H; Nakamura D; Mochizuki M; Kemi M; Tamura K; Kasahara K
Exp Anim; 2019 Nov; 68(4):471-482. PubMed ID: 31118345
[TBL] [Abstract][Full Text] [Related]
35. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.
Sato K; Nie C; Misawa N; Tanaka Y; Ito M; Koyanagi Y
Vaccine; 2010 May; 28 Suppl 2():B32-7. PubMed ID: 20510741
[TBL] [Abstract][Full Text] [Related]
37. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
39. Long-term maintenance of skin immune system in a NOD-Scid IL2rγ(null) mouse model transplanted with human skin.
Soria A; Boccara D; Chonco L; Yahia N; Dufossée M; Cardinaud S; Moris A; Liard C; Joulin-Giet A; Julithe M; Mimoun M; Combadière B; Perrin H
Exp Dermatol; 2014 Nov; 23(11):850-2. PubMed ID: 25091815
[TBL] [Abstract][Full Text] [Related]
40. Data on long-term survival of the NOD/Shi-scid IL-2Rγ
Yamashita Y; Sato T; Noishiki K; Kobayashi K; Uchiyama A; Izumi H; Tamura T; Shikamura M; Oinishi Y; Saito M; Kawamata S
J Toxicol Sci; 2021; 46(10):453-469. PubMed ID: 34602530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
